Correlation Between ACELYRIN, INC and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACELYRIN, INC Common and AN2 Therapeutics, you can compare the effects of market volatilities on ACELYRIN, INC and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and AN2 Therapeutics.
Diversification Opportunities for ACELYRIN, INC and AN2 Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between ACELYRIN, and AN2 is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between ACELYRIN, INC and AN2 Therapeutics
Given the investment horizon of 90 days ACELYRIN, INC Common is expected to under-perform the AN2 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ACELYRIN, INC Common is 1.26 times less risky than AN2 Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 109.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would earn a total of 28.00 from holding AN2 Therapeutics or generate 25.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ACELYRIN, INC Common vs. AN2 Therapeutics
Performance |
| Timeline |
| ACELYRIN, INC Common |
| AN2 Therapeutics |
ACELYRIN, INC and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ACELYRIN, INC and AN2 Therapeutics
The main advantage of trading using opposite ACELYRIN, INC and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| ACELYRIN, INC vs. Inflection Point Acquisition | ACELYRIN, INC vs. Sabre Corpo | ACELYRIN, INC vs. Griffon | ACELYRIN, INC vs. Sapiens International |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |